When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RYTM - Rhythm Pharma (+4%) completes enrollment in setmelanotide obesity study
Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals (RYTM+4.3%) is up on below-average volume in response to its announcement that enrollment has been completed in a Phase 3 clinical trial evaluating setmelanotide in Bardet-Biedl and Alström syndrome patients who are moderately or severely obese.
More news on: Rhythm Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,